British drugmaker GSK said on Friday that its asthma drug, Nucala, met the main goal of a late-stage study in treating patients with chronic obstructive pulmonary disease (COPD), or smoker’s lungs. Patients treated with Nucala and an inhaled maintenance therapy for up to 104… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, […]
The evolution of whole-body endothermy occurred independently in dinosaurs and mammals and was associated with some of the most significant neurocognitive shifts in life’s history. These included a 20-fold increase in neurons and the evolution of new brain structures, supporting similar functions in both lineages. We propose the endothermic brain hypothesis, which holds that elaborations […]
Looking back at the emergence of consciousness in early life, one may repurpose the distinction between the ‘easy’ and the ‘hard problem’ [1]. The easy problem is when consciousness sets on in early development. By contrast, the hard problem is how conscious experiences get off the ground. Bayne et al. [2] address the easy problem […]
© 2024 BETTER/SMARTER.ME, A division of the Institute for the Future of Human Potential
200 First St. SW Rochester, MN 55905 | 1-800-328-IFHP
IFHRP research has not been evaluated by the Food and Drug Administration or any government agency.
IFHRP research is not intended to diagnose, treat, cure, or prevent disease.